The U.S. Food and Drug Administration Wednesday announced it is requesting manufacturers withdraw all prescription and over-the-counter ranitidine drugs — commonly known by the brand name Zantac — from the market immediately. This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine, or NDMA, in ranitidine medications.